Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
Palatin Technologies will announce its Q3 fiscal year 2022 operating results on May 17, 2022, before the U.S. markets open. The company will also host a conference call at 11:00 a.m. ET the same day, reviewing the operating results and providing updates on ongoing programs. Access to the call will be available through the company's website. Palatin focuses on developing innovative biopharmaceutical products to address significant unmet medical needs.
- Scheduled announcement of Q3 fiscal year 2022 results, indicating ongoing business activity.
- Conference call planned for further insights on operating results and program updates.
- None.
CRANBURY, N.J., May 11, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2022 operating results on Tuesday, May 17, 2022, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 17, 2022, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q3 Fiscal Year 2022 Results Press Release | 5/17/2022 at 7:30 a.m. ET |
Q3 Fiscal Year 2022 Conference Call-Live | 5/17/2022 at 11:00 a.m. ET |
US/Canada Dial-In Number: | 1-800-304-0389 |
International Dial-In Number: | 1-313-209-5140 |
Conference ID: | 1376619 |
Q3 Fiscal Year 2022 Conference Call-Replay | 5/17/2022-5/24/2022 |
US/Canada Dial-In Number: | 1-888-203-1112 |
International Dial-In Number: | 1-719-457-0820 |
Replay Passcode: | 1376619 |
Audio Webcast Live and Replay Access | http://www.palatin.com |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-third-quarter-fiscal-year-2022-results-teleconference-and-webcast-to-be-held-on-may-17-2022-301545065.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies announce its Q3 fiscal year 2022 results?
What time is the Palatin Technologies conference call on May 17, 2022?
How can I access the audio webcast of Palatin's conference call?
What is the focus of Palatin Technologies as a biopharmaceutical company?
